Bybit Launches Program to Upskill Sri Lankan Creators with Fully Sponsored Market Education Program

5 Januari 2026, 10:49 am

Sisram Medical Reports Completion of NIFDC Testing for DAXXIFY in China

5 Januari 2026, 9:36 am

Kelun-Biotech Announces Breakthrough Therapy Designation Granted in China for Sacituzumab Tirumotecan (sac-TMT) in Combination with Immunotherapy Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC

5 Januari 2026, 9:29 am

JustMarkets Announces Boost Contest for All Clients

5 Januari 2026, 9:14 am

Patriot Memory Showcases Next-Generation Performance at CES 2026

5 Januari 2026, 8:45 am

Colgate Honors Over 200 Years of Heritage with the Launch of the “Hong Kong Sentiments” Limited Edition Collection

5 Januari 2026, 8:35 am

Top Broker Ranking List Released: WikiFX Highlights KCM Trade’s Growing Influence Across Asia

5 Januari 2026, 8:30 am

Thailand Rings in the New Year at Bangkok’s ‘Times Square of Asia’, Central World

5 Januari 2026, 8:13 am

Autoliv and Tensor Introduce World’s First Foldable Steering Wheel for autonomous driving

5 Januari 2026, 7:28 am

Haikou Embraces New Opportunities as the Hainan Free Trade Port Accelerates Opening-Up

5 Januari 2026, 6:21 am

Samsung Unveils World’s First 130-Inch Micro RGB TV Featuring Next-Generation Colour and Timeless New Design

5 Januari 2026, 6:04 am

Agoda Reveals Growing Interest for Year-End Domestic Travel with Kuala Lumpur at the Forefront in 2025

5 Januari 2026, 6:00 am

Samsung Presents ‘Your Companion to AI Living’ at The First Look during CES 2026

5 Januari 2026, 5:48 am

Manulife Hong Kong Launches Genesis Centurion Insurance Plan and Prestige Achiever Insurance Plan

5 Januari 2026, 5:42 am

Samsung Presents ‘Your Companion to AI Living’ at The First Look during CES 2026

5 Januari 2026, 4:47 am

Samsung Unveils World’s First 130-Inch Micro RGB TV Featuring Next-Generation Color and Bold New Design

5 Januari 2026, 4:44 am

Amorepacific Showcases Innovative Technologies at CES 2026

5 Januari 2026, 4:14 am

GenEditBio Receives FDA Clearance of IND Application for Its Lead In Vivo Genome-Editing Program GEB-101 for TGFBI Corneal Dystrophy

5 Januari 2026, 4:07 am